JP2024096899A5 - - Google Patents

Download PDF

Info

Publication number
JP2024096899A5
JP2024096899A5 JP2024065962A JP2024065962A JP2024096899A5 JP 2024096899 A5 JP2024096899 A5 JP 2024096899A5 JP 2024065962 A JP2024065962 A JP 2024065962A JP 2024065962 A JP2024065962 A JP 2024065962A JP 2024096899 A5 JP2024096899 A5 JP 2024096899A5
Authority
JP
Japan
Prior art keywords
cell
cells
nucleic acid
acid encoding
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024065962A
Other languages
English (en)
Japanese (ja)
Other versions
JP7817708B2 (ja
JP2024096899A (ja
Filing date
Publication date
Priority claimed from JP2020530276A external-priority patent/JP7479635B2/ja
Application filed filed Critical
Publication of JP2024096899A publication Critical patent/JP2024096899A/ja
Publication of JP2024096899A5 publication Critical patent/JP2024096899A5/ja
Priority to JP2025182692A priority Critical patent/JP2026021431A/ja
Application granted granted Critical
Publication of JP7817708B2 publication Critical patent/JP7817708B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2024065962A 2018-07-13 2024-04-16 γδT細胞の製造方法 Active JP7817708B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025182692A JP2026021431A (ja) 2018-07-13 2025-10-29 γδT細胞の製造方法

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP2018133727 2018-07-13
JP2018133727 2018-07-13
JP2019117891 2019-06-25
JP2019117891 2019-06-25
JP2020530276A JP7479635B2 (ja) 2018-07-13 2019-07-12 γδT細胞の製造方法
PCT/JP2019/027697 WO2020013315A1 (ja) 2018-07-13 2019-07-12 γδT細胞の製造方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020530276A Division JP7479635B2 (ja) 2018-07-13 2019-07-12 γδT細胞の製造方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025182692A Division JP2026021431A (ja) 2018-07-13 2025-10-29 γδT細胞の製造方法

Publications (3)

Publication Number Publication Date
JP2024096899A JP2024096899A (ja) 2024-07-17
JP2024096899A5 true JP2024096899A5 (https=) 2024-11-01
JP7817708B2 JP7817708B2 (ja) 2026-02-19

Family

ID=69143058

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020530276A Active JP7479635B2 (ja) 2018-07-13 2019-07-12 γδT細胞の製造方法
JP2024065962A Active JP7817708B2 (ja) 2018-07-13 2024-04-16 γδT細胞の製造方法
JP2025182692A Pending JP2026021431A (ja) 2018-07-13 2025-10-29 γδT細胞の製造方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020530276A Active JP7479635B2 (ja) 2018-07-13 2019-07-12 γδT細胞の製造方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025182692A Pending JP2026021431A (ja) 2018-07-13 2025-10-29 γδT細胞の製造方法

Country Status (14)

Country Link
US (2) US12391739B2 (https=)
EP (1) EP3822342A4 (https=)
JP (3) JP7479635B2 (https=)
KR (1) KR20210030373A (https=)
CN (1) CN112513256A (https=)
AU (1) AU2019302207B2 (https=)
BR (1) BR112021000437A2 (https=)
CA (1) CA3106089A1 (https=)
CO (1) CO2021001064A2 (https=)
IL (1) IL280041A (https=)
MX (1) MX2021000459A (https=)
SG (1) SG11202100260QA (https=)
TW (1) TW202020145A (https=)
WO (1) WO2020013315A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11629340B2 (en) 2017-03-03 2023-04-18 Obsidian Therapeutics, Inc. DHFR tunable protein regulation
TW202020145A (zh) * 2018-07-13 2020-06-01 國立大學法人京都大學 γδT細胞的製造方法
CN109337870B (zh) * 2018-12-24 2020-07-03 广东暨德康民生物科技有限责任公司 人Vγ9Vδ2T细胞扩增方法与培养基
US20230016034A1 (en) * 2019-12-06 2023-01-19 Fate Therapeutics, Inc. ENHANCEMENT OF iPSC-DERIVED EFFECTOR IMMUNE CELL USING SMALL COMPOUNDS
US20230257705A1 (en) 2020-06-17 2023-08-17 Kyoto University Chimeric antigen receptor-expressing immunocompetent cells
WO2022059780A1 (ja) * 2020-09-18 2022-03-24 サイアス株式会社 iPS細胞を介する再生T細胞の製造方法
CN116964194A (zh) * 2021-02-05 2023-10-27 国立大学法人神户大学 诱导性多能干细胞衍生的γδT细胞及其产生方法
BR112023018844A2 (pt) * 2021-04-07 2023-10-10 Century Therapeutics Inc Composições e métodos para geração de células t gama-delta de células-tronco pluripotentes induzidas
CN113583955A (zh) * 2021-08-24 2021-11-02 羽铂精制生物技术(成都)有限公司 一种因子法扩增t细胞的培养基及培养方法
EP4416271A4 (en) * 2021-10-14 2025-09-03 Appia Bio Inc ENGINEERING T-CELL STEM CELLS WITH MULTIPLE T-CELL RECEPTORS
CA3238172A1 (en) * 2021-11-12 2023-05-19 Janssen Biotech, Inc. Materials and methods for improved expansion and uses of immune cells
US20250195655A1 (en) 2022-02-04 2025-06-19 Kyoto University T cell production method
EP4504247A1 (en) * 2022-04-04 2025-02-12 Gammadelta Therapeutics Ltd Novel gene armoring
CN119110845A (zh) * 2022-04-04 2024-12-10 伽马三角洲疗法有限公司 表达抗间皮素car的细胞
EP4508193A4 (en) * 2022-04-11 2026-04-29 In8Bio Inc IPSC-BASED GAMMA-DELTA T LYMPHOCYTES: COMPOSITIONS AND METHODS OF USE
CN118931834B (zh) * 2024-03-07 2025-09-16 珠海善行免疫微生态产业研究院有限公司 一种人Vγ9Vδ2T细胞扩增培养基及其扩增培养方法
CN119530215A (zh) * 2024-11-27 2025-02-28 珠海医米诺赛医学检验有限公司 一种血液处理液及利用该处理液进行染色体核型分析的方法

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937190A (en) 1987-10-15 1990-06-26 Wisconsin Alumni Research Foundation Translation enhancer
ES2336302T3 (es) 2000-04-03 2010-04-12 Therapure Biopharma Inc. Produccion de celulas ttcr gamma delta.
US9453219B2 (en) 2003-05-15 2016-09-27 Mello Biotech Taiwan Co., Ltd. Cosmetic designs and products using intronic RNA
WO2006006720A1 (ja) 2004-07-13 2006-01-19 Medinet., Co.Ltd γδT細胞の培養方法、γδT細胞及び治療・予防剤
US8048999B2 (en) 2005-12-13 2011-11-01 Kyoto University Nuclear reprogramming factor
JP5813321B2 (ja) 2007-03-23 2015-11-17 ウィスコンシン アラムニ リサーチ ファンデーション 体細胞の再プログラム化
KR101363928B1 (ko) 2007-06-11 2014-02-19 고쿠리츠다이가쿠호진 미에다이가쿠 특이적 유전자 발현 방법
JP2008307007A (ja) 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
ES2799897T3 (es) 2007-08-31 2020-12-22 Whitehead Inst Biomedical Res Estimulación de la vía wnt en la reprogramación de células somáticas
KR101564044B1 (ko) 2007-10-31 2015-10-28 고쿠리츠 다이가쿠 호진 교토 다이가쿠 핵초기화 방법
JP5558097B2 (ja) 2007-12-10 2014-07-23 国立大学法人京都大学 効率的な核初期化方法
WO2009079007A1 (en) 2007-12-17 2009-06-25 Gliamed, Inc. Stem-like cells and method for reprogramming adult mammalian somatic cells
WO2009091659A2 (en) 2008-01-16 2009-07-23 Shi-Lung Lin Generation of tumor-free embryonic stem-like pluripotent cells using inducible recombinant rna agents
US20100330677A1 (en) 2008-02-11 2010-12-30 Cambridge Enterprise Limited Improved Reprogramming of Mammalian Cells, and Cells Obtained
EP2090649A1 (en) 2008-02-13 2009-08-19 Fondazione Telethon Method for reprogramming differentiated cells
WO2009102983A2 (en) 2008-02-15 2009-08-20 President And Fellows Of Harvard College Efficient induction of pluripotent stem cells using small molecule compounds
MX2010010165A (es) 2008-03-17 2010-11-25 Scripps Research Inst Procedimientos quimicos y geneticos combinados para generacion de celulas madre pluripotentes inducidas.
WO2009114949A1 (en) 2008-03-20 2009-09-24 UNIVERSITé LAVAL Methods for deprogramming somatic cells and uses thereof
KR20110019727A (ko) 2008-04-07 2011-02-28 뉴포텐셜, 인크. Rna 간섭을 통한 다능 유전자의 유도에 의한 세포 재프로그래밍
CA2695590C (en) 2008-06-27 2018-01-09 Kyoto University Method of efficiently establishing induced pluripotent stem cells
JP4281071B1 (ja) * 2008-07-10 2009-06-17 学校法人兵庫医科大学 Vγ9Vδ2T細胞の増殖剤、活性化Vγ9Vδ2T細胞の製造方法およびこれらの利用
US9453204B2 (en) 2008-07-14 2016-09-27 Oklahoma Medical Research Foundation Production of pluripotent cells through inhibition of bright/ARID3a function
WO2010147612A1 (en) 2009-06-18 2010-12-23 Lixte Biotechnology, Inc. Methods of modulating cell regulation by inhibiting p53
US20120021519A1 (en) 2008-09-19 2012-01-26 Presidents And Fellows Of Harvard College Efficient induction of pluripotent stem cells using small molecule compounds
WO2010033920A2 (en) 2008-09-19 2010-03-25 Whitehead Institute For Biomedical Research Compositions and methods for enhancing cell reprogramming
WO2010042800A1 (en) 2008-10-10 2010-04-15 Nevada Cancer Institute Methods of reprogramming somatic cells and methods of use for such cells
JP2012507258A (ja) 2008-10-30 2012-03-29 国立大学法人京都大学 人工多能性幹細胞の作製方法
US20110059526A1 (en) 2008-11-12 2011-03-10 Nupotential, Inc. Reprogramming a cell by inducing a pluripotent gene through use of an hdac modulator
EP2376626A4 (en) 2008-12-13 2012-10-17 Dna Microarray MICRO-ENVIRONMENTAL NICHE ASSAY FOR SCREENING OF INDUCED PLURIPOTENT STEM CELLS (CIPS)
WO2010098419A1 (en) 2009-02-27 2010-09-02 Kyoto University Novel nuclear reprogramming substance
WO2010102267A2 (en) 2009-03-06 2010-09-10 Ipierian, Inc. Tgf-beta pathway inhibitors for enhancement of cellular reprogramming of human cells
US20120076762A1 (en) 2009-03-25 2012-03-29 The Salk Institute For Biological Studies Induced pluripotent stem cell generation using two factors and p53 inactivation
WO2010111409A2 (en) 2009-03-25 2010-09-30 The Salk Institute For Biological Studies Pluripotent stem cells
WO2010115050A2 (en) 2009-04-01 2010-10-07 The Regents Of The University Of California Embryonic stem cell specific micrornas promote induced pluripotency
WO2010124290A2 (en) 2009-04-24 2010-10-28 Whitehead Institute For Biomedical Research Compositions and methods for deriving or culturing pluripotent cells
WO2010141801A2 (en) 2009-06-05 2010-12-09 Cellular Dynamics International, Inc. Reprogramming t cells and hematophietic cells
WO2010147395A2 (en) 2009-06-16 2010-12-23 Korea Research Institute Of Bioscience And Biotechnology Medium composition comprising neuropeptide y for the generation, maintenance, prologned undifferentiated growth of pluripotent stem cells and method of culturing pluripotent stem cell using the same
US9206394B2 (en) * 2010-02-03 2015-12-08 The University Of Tokyo Method for reconstructing immune function using pluripotent stem cells
SG11201402502RA (en) 2011-11-21 2015-01-29 Sunnybrook Res Inst Populations of hematopoietic progenitors and methods of enriching stem cells therefor
WO2014165707A2 (en) * 2013-04-03 2014-10-09 Memorial Sloan-Kettering Cancer Center Effective generation of tumor-targeted t-cells derived from pluripotent stem cells
AU2015290561A1 (en) 2014-07-18 2017-03-09 Hiroshi Kawamoto Method for generating pluripotent stem cells bearing antigen specific T cell receptor genes
JP6715482B2 (ja) * 2014-07-18 2020-07-01 国立大学法人京都大学 多能性幹細胞から免疫細胞療法用t細胞を誘導する方法
US20170333480A1 (en) * 2014-11-05 2017-11-23 Board Of Regents, The University Of Texas System Gene modified immune effector cells and engineered cells for expansion of immune effector cells
US10660915B2 (en) * 2014-11-13 2020-05-26 Kyoto University Method for induction of T cells from pluripotent stem cells
GB201421716D0 (en) 2014-12-05 2015-01-21 King S College London Cell expansion procedure
ES2965437T3 (es) 2015-09-03 2024-04-15 Uab Res Found Células T modificadas genéticamente resistentes a fármacos y procedimientos de utilización de las mismas
WO2017065288A1 (ja) * 2015-10-15 2017-04-20 国立大学法人京都大学 多能性幹細胞からcd4陽性t細胞を製造する方法
SG11201803419PA (en) 2015-10-30 2018-05-30 The Regents Of The Universtiy Of California Methods of generating t-cells from stem cells and immunotherapeutic methods using the t-cells
LT3444334T (lt) * 2016-04-15 2021-12-10 Kyoto University Antigenui specifinių cd8 teigiamų t ląstelių indikavimo būdas
US11578310B2 (en) * 2016-06-23 2023-02-14 Kyoto University Method for producing CD4/CD8 double-positive T cells
CN110199017A (zh) 2017-01-20 2019-09-03 国立大学法人京都大学 CD8α+β+细胞毒性T细胞的制备方法
JP7224021B2 (ja) 2017-02-03 2023-02-17 国立大学法人神戸大学 人工多能性幹細胞の作製方法
EP3580332B1 (en) 2017-02-07 2026-04-15 Agency for Science, Technology And Research Methods and kits for generating mimetic innate immune cells from pluripotent stem cells
JP2018133727A (ja) 2017-02-16 2018-08-23 富士通株式会社 無線通信システム、無線通信装置、及びビームパターン決定方法
JP7171055B2 (ja) * 2017-03-14 2022-11-15 国立大学法人京都大学 多能性幹細胞からヘルパーt細胞を製造する方法
JP7109916B2 (ja) 2017-12-27 2022-08-01 株式会社ディスコ 分割装置
TW202020145A (zh) * 2018-07-13 2020-06-01 國立大學法人京都大學 γδT細胞的製造方法
EP3831936A4 (en) * 2018-07-31 2022-04-13 Thyas Co. Ltd. METHOD FOR PRODUCING A REGENERATED T LYMPHOCYTE POPULATION USING IPS CELLS
EP4053267A4 (en) * 2019-11-01 2024-03-20 Kyoto University Method for producing t cell
CA3162755A1 (en) * 2019-11-25 2021-06-03 Kyoto University T-cell master cell bank
WO2022059780A1 (ja) * 2020-09-18 2022-03-24 サイアス株式会社 iPS細胞を介する再生T細胞の製造方法
EP4219707A4 (en) * 2020-09-24 2024-11-13 Kyoto University METHOD FOR PRODUCING AN EFFECTOR CELL WITH DESIRED SPECIFICITY
US20240052309A1 (en) * 2021-01-04 2024-02-15 Thyas Co. Ltd. Method for producing regenerated t cell via ips cell

Similar Documents

Publication Publication Date Title
JP2024096899A5 (https=)
JP2026021431A5 (https=)
JP2021520849A5 (https=)
JP2023055884A5 (https=)
CN109735497A (zh) 一种提高胎儿血红蛋白表达水平的方法
JP2020511131A5 (https=)
JP2003527856A5 (https=)
JP2022542399A5 (https=)
JP2022536951A5 (https=)
DE69230993D1 (de) Rekombinante viren vektoren zur expression in muskelzellen
WO2004101756A3 (en) Ovr110 antibody compositions and methods of use
JP2021528096A5 (https=)
JP2021525519A5 (https=)
JP2024513958A5 (https=)
JP2023521875A5 (https=)
JP2022522231A5 (https=)
JP2024513522A5 (https=)
JP2024539089A5 (https=)
JP2024527997A5 (https=)
JP2023504185A5 (https=)
Stévenin et al. Relationship between nuclear giant-size dRNA and microsomal dRNA of rat brain
MX2024013891A (es) Vacunas y métodos para usarlas para tratar cáncer relacionado con wnt
JP2022524958A5 (https=)
JP2007509063A5 (https=)
JP2019508056A5 (https=)